These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4220793)

  • 1. Effects of heparin, plasmin, dextran, and low molecular dextran on bioelectrically induced thromboses.
    Flemma RJ; Silver D; Anlyan WG
    Surg Forum; 1965; 16():123-4. PubMed ID: 4220793
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of heparin, plasmin, dextran and low-molecular-weight dextran on electrically induced thromboses.
    Flemma RJ; Acinapura AJ; Silver D; Anlyan WG
    Am Surg; 1966 Jan; 32(1):17-9. PubMed ID: 4221357
    [No Abstract]   [Full Text] [Related]  

  • 3. An evaluation of dextran in the prevention and treatment of thrombosis.
    Silver D
    Acta Chir Scand Suppl; 1968; 387():69-72. PubMed ID: 4240350
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of heparin, tranexamic acid, and low molecular weight dextran on pulmonary microvascular occlusions following aortic cross-clamping.
    Lim RC; Bergentz SE
    Bibl Anat; 1969; 10():480-8. PubMed ID: 5407404
    [No Abstract]   [Full Text] [Related]  

  • 5. DEXTRAN THERAPY IN THROMBOPHLEBITIS.
    SAWYER RB; MONCRIEF JA; CANIZARO PC
    JAMA; 1965 Mar; 191():740-2. PubMed ID: 14245515
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of heparin and low molecular weight dextran on the patency of autogenous vein grafts in the venous system.
    Hobson RW; Croom RD; Rich NM
    Ann Surg; 1973 Dec; 178(6):773-6. PubMed ID: 4759408
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of histones and dextran on some properties of fibrin, particularly on its susceptibility to plasmin.
    Kppeć M; Wegrzynowicz Z; Zajdel M; Sawecka J; Szumiel I
    Thromb Res; 1974 Sep; 5(3):359-74. PubMed ID: 4280155
    [No Abstract]   [Full Text] [Related]  

  • 8. A study of the influence of heparin and low molecular weight dextran on tourniquet palsy.
    RHEA WG; FOSTER JH
    Surg Forum; 1961; 12():437-8. PubMed ID: 14491760
    [No Abstract]   [Full Text] [Related]  

  • 9. The independent yet synergistic effects of heparin and dextran.
    Bloom WL; Brewer S
    Acta Chir Scand Suppl; 1968; 387():53-7. PubMed ID: 5256244
    [No Abstract]   [Full Text] [Related]  

  • 10. THE ROLE OF LOW MOLECULAR WEIGHT DEXTRAN IN THE MANAGEMENT OF VENOUS THROMBOSIS.
    ERNST CB; FRY WJ; DEWEESE MS; KRAFT RO
    Surg Gynecol Obstet; 1964 Dec; 119():1243-7. PubMed ID: 14227749
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental arterial thrombus prevention and renal function in sheep after infusion with low molecular weight dextran and dextran 70,000.
    Hunt PS; Reeve TS
    Ann Surg; 1967 Jul; 166(1):51-8. PubMed ID: 6028842
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-molecular-weight dextran in the treatment of experimental frostbite.
    Webster DR; Bonn G
    Can J Surg; 1965 Oct; 8(4):423-7. PubMed ID: 5834732
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental data on the effect of fibrinolysin on coronary circulation].
    Ponomareva AG; Zhdanov IuE; Zaĭtsev II; Gorokhov NS
    Biull Eksp Biol Med; 1966 May; 61(5):24-6. PubMed ID: 4236076
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative anticoagulant effects of coumadin, heparin, and fibrinolysin on direct-current thrombosis of rat mesoappendix vessels.
    Lustrin I; Breen H; Reardon J; Wesolowski SA; Sawyer PN
    Surgery; 1965 Nov; 58(5):857-61. PubMed ID: 4221183
    [No Abstract]   [Full Text] [Related]  

  • 15. [Protective effect of combined injection of fibrinolysin and heparin against thrombogenesis in animals during the pre-thrombotic state and in experimental atherosclerosis].
    Andreenko GV; Bazaz'ian GG; Sytina NP
    Biull Eksp Biol Med; 1965 Jul; 60(7):31-4. PubMed ID: 4222542
    [No Abstract]   [Full Text] [Related]  

  • 16. The lysis of arterial thrombi in rabbits and dogs by use of activated human plasminogen (fibrinolysin) (plasmin).
    GROSSI CE; CLIFFTON EE
    Surgery; 1955 May; 37(5):794-802. PubMed ID: 14373295
    [No Abstract]   [Full Text] [Related]  

  • 17. Study of the effect of the administration of dextran and physiologic saline solution on the colloidal osmotic pressure of the plasma in splenectomized dogs following hemorrhage.
    ECKERT C; WEICHSELBAUM TE; SIGHTS R; MILLER V
    Surg Forum; 1953 Oct; 4():731-6. PubMed ID: 13187375
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of the in vitro and in vivo effects of a synthetic heparin-like anticoagulant: dextran sulphate.
    HJORT P; STORMORKEN H; GILJE O
    Scand J Clin Lab Invest; 1957; 9 Suppl 29():1-86. PubMed ID: 13506569
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of antithrombogenic properties of dextran solutions.
    Robbins LB; Carlisle BB; Foster JH
    Am Surg; 1966 Nov; 32(11):798-804. PubMed ID: 5926858
    [No Abstract]   [Full Text] [Related]  

  • 20. Vascular effects of heparin, dextran sulphate, and 5-hydroxytryptamine.
    LAMBERT HP
    Clin Sci; 1958 Nov; 17(4):621-8. PubMed ID: 13608972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.